Exploring the Relationship Between ICOPE Framework and Frailty Among Community-dwelling Elderly Individuals

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT06140212
Collaborator
(none)
150
1
4.6
32.6

Study Details

Study Description

Brief Summary

This study aims to compare the results obtained from the self-administration and interview version of the Chinese ICOPE screening tools and examine the relationship between ICOPE and frailty among community-dwelling elderly in Taiwan.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Montreal Cognitive Assessment (MoCA)
  • Behavioral: Chinese ICOPE screening tool (self-administration and interview versions)
  • Behavioral: Frailty status assessment (Edmonton frail scale and Frailty criteria by Dr. Fried)

Detailed Description

The elderly population is increasing rapidly in the world. The prevalence of frailty is directly correlated with advancing age in community- dwelling elderly. The World Health Organization (WHO) published the Integrated Care for older people (ICOPE) screening tool rapid screening health state of the elderly for early prevention and delay the onset of disability. However, there is still insufficient research on the correlation between the interview version and self-administration of Chinese ICOPE screening tools and ICOPE and frailty. Therefore, this study aims to compare the results obtained from the self-administration and interview version of the Chinese ICOPE screening tools and examine the relationship between ICOPE and frailty among community-dwelling elderly in Taiwan.

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Exploring the Relationship Between the Integrated Care for Older People (ICOPE) Framework and Frailty Among Community-dwelling Elderly Individuals
Anticipated Study Start Date :
Nov 13, 2023
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Apr 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Decline ICOPE group

The elderly individuals who have at least one impairment in ICOPE screening domains.

Behavioral: Montreal Cognitive Assessment (MoCA)
MoCA would be used to assess participants cognitive functioning.

Behavioral: Chinese ICOPE screening tool (self-administration and interview versions)
The ICOPE screening tool would be used to assess participants health status, including cognitive decline, auditory and visual capabilities, mobility restrictions, nutritional status, and depressive symptoms.

Behavioral: Frailty status assessment (Edmonton frail scale and Frailty criteria by Dr. Fried)
The Edmonton frail scale and Frailty criteria by Dr. Fried would be used to assess participants frailty status.

Non-decline ICOPE group

The elderly individuals who do not have any impairment in ICOPE screening domains.

Behavioral: Montreal Cognitive Assessment (MoCA)
MoCA would be used to assess participants cognitive functioning.

Behavioral: Chinese ICOPE screening tool (self-administration and interview versions)
The ICOPE screening tool would be used to assess participants health status, including cognitive decline, auditory and visual capabilities, mobility restrictions, nutritional status, and depressive symptoms.

Behavioral: Frailty status assessment (Edmonton frail scale and Frailty criteria by Dr. Fried)
The Edmonton frail scale and Frailty criteria by Dr. Fried would be used to assess participants frailty status.

Outcome Measures

Primary Outcome Measures

  1. Intrinsic capacity [The ICOPE screening tool assessment would take about 10 minutes]

    ICOPE screening tool (self-administration and interview version) would be used to evaluate the intrinsic capacity(IC), including cognitive decline, auditory and visual capabilities, mobility restrictions, nutritional status, and depressive symptoms) of the participants. Each question requires a binary response, either 'yes' or 'no'. A "total score" will be determined by summing the number of IC impairments, which have a score range of 0-6, with higher scores indicating a greater degree of impairment.

  2. Phenotype of frailty status [The phenotype of frailty status assessment would take about 10 minutes]

    Frailty criteria by Dr. Fried would be used to evaluate the frail status of the participants.The Dr. Fried phenotype of frailty comprises five components, unintentional weight loss, exhaustion, weakness, slowness, and low activity. Individuals who exhibit three or more indicators are classified as frail, those with one to two indicators are categorized as pre-frail, and those with no indicators are characterized as robust.

  3. Accumulated frailty status [The accumulated frailty status assessment would take about 10 minutes]

    Edmonton frail scale(EFS) would be used to evaluate the frail status of the participants. EFS assesses a wide range of nine domains through 11 questions. These domains cover cognition, general health status, functional independence, social support, medication use, nutrition, mood, continence, and functional performance. The total score of EFS ranges from 0 to 17, where scores of 0-5 indicate not being frail, 6-7 indicate being vulnerable, 8-9 indicate mild frailty, 10-11 indicate moderate frailty and 12-17 indicate severe frailty.

Secondary Outcome Measures

  1. Cognitive status [The cognitive status assessment would take about 10 minutes]

    MoCA would be used to evaluate the cognitive functioning of the participants. MOCA comprises attention and concentration, executive function, memory, language ability, visuospatial construction, abstract concepts, calculation, and orientation. The cumulative score amounts to 30 points, with a minimum standard of 26 points or higher. 25-18 points indicate mild cognitive impairment, 17-10 points indicate moderate cognitive impairment, fewer than 10 points indicate severe cognitive impairment.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • ≥ 65 years old

  • Community-dwelling elderly

  • Walking independently (with/without assistive devices)

Exclusion Criteria:
  • Participants with a MoCA score < 25

  • Being unable to give informed consent (e.g., aphasia, deafness, and blindness)

  • Being unable to finish all the physical and screening assessment assessments

Contacts and Locations

Locations

Site City State Country Postal Code
1 School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University Taipei Zhongzheng Taiwan 100

Sponsors and Collaborators

  • National Taiwan University Hospital

Investigators

  • Study Chair: Li-Ying Wang, PhD, National Taiwan University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT06140212
Other Study ID Numbers:
  • 202310067RINC
First Posted:
Nov 18, 2023
Last Update Posted:
Nov 18, 2023
Last Verified:
Nov 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by National Taiwan University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 18, 2023